Nothing Special   »   [go: up one dir, main page]

BR0208367B1 - Composição farmacêutica para o tratamento de infecções oculares, para aplicação local, processo para a preparação de uma composição farmacêutica de colírio, adequada para aplicação local em oftalmologia, e, utilização de azitromicina - Google Patents

Composição farmacêutica para o tratamento de infecções oculares, para aplicação local, processo para a preparação de uma composição farmacêutica de colírio, adequada para aplicação local em oftalmologia, e, utilização de azitromicina

Info

Publication number
BR0208367B1
BR0208367B1 BRPI0208367-1B1A BR0208367A BR0208367B1 BR 0208367 B1 BR0208367 B1 BR 0208367B1 BR 0208367 A BR0208367 A BR 0208367A BR 0208367 B1 BR0208367 B1 BR 0208367B1
Authority
BR
Brazil
Prior art keywords
pharmaceutical composition
local application
eye
azithromycin
ophthalmology
Prior art date
Application number
BRPI0208367-1B1A
Other languages
English (en)
Other versions
BRPI0208367B8 (pt
BR0208367A (pt
Inventor
Jacques Luyckx
Frederic Pilotaz
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BR0208367A publication Critical patent/BR0208367A/pt
Publication of BR0208367B1 publication Critical patent/BR0208367B1/pt
Publication of BRPI0208367B8 publication Critical patent/BRPI0208367B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
BRPI0208367A 2001-04-12 2002-04-11 composição farmacêutica para o tratamento de infecções oculares, para aplicação local, processo para a preparação de uma composição farmacêutica de colírio, adequada para aplicação local em oftalmologia, e, utilização de azitromicina BRPI0208367B8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0105114A FR2823441B1 (fr) 2001-04-12 2001-04-12 Composition pharmaceutique a base de macrolides pour application locale en ophtalmologie et son procede de preparation
PCT/FR2002/001263 WO2002083178A1 (fr) 2001-04-12 2002-04-11 Composition pharmaceutique a base de macrolides pour application locale en ophtalmologie

Publications (3)

Publication Number Publication Date
BR0208367A BR0208367A (pt) 2004-03-09
BR0208367B1 true BR0208367B1 (pt) 2013-11-12
BRPI0208367B8 BRPI0208367B8 (pt) 2021-05-25

Family

ID=8862340

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0208367A BRPI0208367B8 (pt) 2001-04-12 2002-04-11 composição farmacêutica para o tratamento de infecções oculares, para aplicação local, processo para a preparação de uma composição farmacêutica de colírio, adequada para aplicação local em oftalmologia, e, utilização de azitromicina

Country Status (31)

Country Link
US (1) US7064109B2 (pt)
EP (1) EP1377316B1 (pt)
JP (2) JP4558275B2 (pt)
KR (1) KR100835002B1 (pt)
CN (1) CN1496270B (pt)
AR (1) AR034033A1 (pt)
AT (1) ATE397460T1 (pt)
BR (1) BRPI0208367B8 (pt)
CA (1) CA2443728C (pt)
CY (1) CY1108302T1 (pt)
CZ (1) CZ300213B6 (pt)
DE (1) DE60226962D1 (pt)
DK (1) DK1377316T3 (pt)
EA (1) EA008088B1 (pt)
EG (1) EG23169A (pt)
ES (1) ES2307754T3 (pt)
FR (1) FR2823441B1 (pt)
HK (1) HK1065708A1 (pt)
HR (1) HRP20030907B1 (pt)
HU (1) HU230459B1 (pt)
MA (1) MA27005A1 (pt)
MX (1) MXPA03009349A (pt)
OA (1) OA12462A (pt)
PA (1) PA8543401A1 (pt)
PE (1) PE20021082A1 (pt)
PL (1) PL204403B1 (pt)
PT (1) PT1377316E (pt)
SI (1) SI1377316T1 (pt)
TN (1) TNSN03091A1 (pt)
WO (1) WO2002083178A1 (pt)
ZA (1) ZA200307718B (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1655021B1 (en) * 2004-11-09 2008-10-29 Novagali Pharma SA Oil-in-water type emulsion with low concentration of cationic agent and positive zeta potential
FR2884716B1 (fr) * 2005-04-22 2009-08-21 Thea Sa Lab Utilisation de l'azithromycine pour la fabrication d'un medicament destine au traitement des infections oculaires
WO2007074904A1 (ja) * 2005-12-28 2007-07-05 Wakamoto Pharmaceutical Co., Ltd. 水性医薬組成物
EP2131809A2 (en) * 2007-02-28 2009-12-16 Aciex Therapeutics, Inc. Methods and compositions for normalizing meibomian gland secretions
US20100158821A1 (en) * 2008-12-22 2010-06-24 Eastman Chemical Company Antimicrobial agents, compositions and products containing the same, and methods of using the compositions and products
CN101780105B (zh) * 2009-01-20 2011-09-28 沈阳兴齐制药有限公司 小牛血去蛋白提取物的滴眼液
EP2228058A1 (en) 2009-03-04 2010-09-15 Novagali Pharma S.A. Anionic oil-in-water emulsion containing prostaglandins and uses thereof
US8106111B2 (en) * 2009-05-15 2012-01-31 Eastman Chemical Company Antimicrobial effect of cycloaliphatic diol antimicrobial agents in coating compositions
EP2394636B1 (en) * 2010-05-28 2014-03-19 Novagali Pharma S.A. Method for treating retinal conditions using an intraocular tamponade
EP2389939A1 (en) 2010-05-28 2011-11-30 Novagali Pharma S.A. Use of prostaglandins F2alpha and analogues for the healing of corneal and conjunctival lesions
US9044508B2 (en) * 2013-03-15 2015-06-02 Insite Vision Corporation Concentrated aqueous azalide formulations
EP3478269A4 (en) * 2016-06-29 2020-04-08 Otonomy, Inc. OTIC FORMULATIONS BASED ON TRIGLYCERIDES AND THEIR USES
EP3266446B1 (en) * 2016-07-07 2018-11-21 Laboratorios SALVAT, S.A. Ophthalmic composition comprising castor oil and medium chain triglyceride

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1152644A (en) * 1966-07-01 1969-05-21 Abbott Lab Stable Solutions of Erythromycin Free Base
JPS6468328A (en) * 1987-09-09 1989-03-14 Suntory Ltd Anticorneoulcerative
JP2563336B2 (ja) * 1987-06-01 1996-12-11 エーザイ株式会社 角膜透過促進点眼剤
FR2746035B1 (fr) * 1996-03-15 1998-06-12 Microparticules de gel composite susceptibles d'etre utilisees comme vecteur(s) de principe(s) actif(s), l'un de leurs procedes de preparation et leurs applications
EP0925789B2 (en) * 1997-12-02 2009-06-17 Pfizer Products Inc. Use of azithromycin in the topical treatment of ocular infections
JP2000159659A (ja) * 1998-11-30 2000-06-13 Kazuo Tsubota 眼科用人工涙液
US6239113B1 (en) * 1999-03-31 2001-05-29 Insite Vision, Incorporated Topical treatment or prevention of ocular infections

Also Published As

Publication number Publication date
SI1377316T1 (sl) 2008-10-31
FR2823441B1 (fr) 2004-09-10
JP4558275B2 (ja) 2010-10-06
CZ20032771A3 (cs) 2004-01-14
KR20030088466A (ko) 2003-11-19
HUP0303864A3 (en) 2012-07-30
EP1377316A1 (fr) 2004-01-07
FR2823441A1 (fr) 2002-10-18
MXPA03009349A (es) 2004-11-12
HUP0303864A2 (hu) 2004-03-01
CN1496270A (zh) 2004-05-12
PA8543401A1 (es) 2003-01-24
CZ300213B6 (cs) 2009-03-18
CA2443728C (fr) 2011-01-04
JP5170780B2 (ja) 2013-03-27
PE20021082A1 (es) 2002-12-18
CN1496270B (zh) 2010-05-26
WO2002083178A1 (fr) 2002-10-24
PL204403B1 (pl) 2010-01-29
KR100835002B1 (ko) 2008-06-09
BRPI0208367B8 (pt) 2021-05-25
OA12462A (fr) 2006-06-24
DK1377316T3 (da) 2008-09-22
CY1108302T1 (el) 2014-02-12
PT1377316E (pt) 2008-09-15
HK1065708A1 (en) 2005-03-04
BR0208367A (pt) 2004-03-09
CA2443728A1 (fr) 2002-10-24
PL363538A1 (en) 2004-11-29
ATE397460T1 (de) 2008-06-15
US20040197340A1 (en) 2004-10-07
EG23169A (en) 2004-06-30
JP2010043109A (ja) 2010-02-25
ES2307754T3 (es) 2008-12-01
TNSN03091A1 (fr) 2005-12-23
EA200301108A1 (ru) 2004-04-29
EA008088B1 (ru) 2007-02-27
DE60226962D1 (de) 2008-07-17
JP2004526763A (ja) 2004-09-02
HRP20030907B1 (en) 2010-04-30
HU230459B1 (hu) 2016-07-28
US7064109B2 (en) 2006-06-20
HRP20030907A2 (en) 2004-02-29
AR034033A1 (es) 2004-01-21
MA27005A1 (fr) 2004-12-20
ZA200307718B (en) 2004-09-02
EP1377316B1 (fr) 2008-06-04

Similar Documents

Publication Publication Date Title
EE200300370A (et) Atsüülitud 6,7,8,9-tetrahüdro-5H-bensotsükloheptenüülamiinid, nende valmistamismeetod, kasutamine ja farmatseutiline preparaat
BR0207760A (pt) Composição farmacêutica, uso da mesma, métodos para o tratamento de dor e de inflamação, e, processo para a preparação de uma composição
EE200300369A (et) Atsüülitud indanüülamiinid, nende valmistamismeetod, kasutamine ja farmatseutiline preparaat
PT1523489E (pt) Profármacos de nucleósido modificado em 2' e 3' para tratamento de infecções por flaviridae
EE200300587A (et) Vedel farmatseutiline kompositsioon, selle valmistamise meetod ja kasutamine
BR0208367B1 (pt) Composição farmacêutica para o tratamento de infecções oculares, para aplicação local, processo para a preparação de uma composição farmacêutica de colírio, adequada para aplicação local em oftalmologia, e, utilização de azitromicina
BR0008053B1 (pt) processo e aparelho para fabricaÇço de artigos absorventes descartÁveis.
AU2003246102A8 (en) Method of examining allergic disease and drug for treating the same
BRPI0206509B8 (pt) processo para formular, para administração parenteral, um análogo de epotilona, preparação farmacêutica, processo para formar uma composição farmacêutica para administração parental, composição farmacêutica e uso de um análogo de epotilona na preparação de uma composição farmacêutica para o tratamento de câncer
EP1551399A4 (en) METHOD FOR THE TOPICAL TREATMENT OF EYE DISEASES AND COMPOSITION AND DEVICE FOR THIS TREATMENT
PT1313489E (pt) Composicoes farmaceuticas para o tratamento de mucosite, estomatite e sindroma de behcet
PT1392292E (pt) Piranoindazoles e sua utilizacao para o tratamento de glaucoma
PT1183029E (pt) Preparado farmaceutico contendo contendo o principio activo diamorfina e sua utilizacao num processo para o tratamento da dependencia de opiaceos
BR0013010B1 (pt) Formulação aquosa de cloreto de sódio de moxifloxacina, processo para sua preparação e aplicação da referida formulação, bem como preparado de combinação e aplicação de uma solução aquosa de cloridrato de moxifloxacina
EE200300327A (et) Uurea derivaadid, nende valmistamismeetodid, kasutamine ja farmatseutiline kompositsioon
PT1228028E (pt) Sais de hidroxieicosatetraeniato, composicoes e metodos para utilizacao no tratamento de perturbacoes da secura ocular
EE200400028A (et) Ravimpreparaat, selle valmistamise meetod ja selle kasutamine meditsiinis
IT1305313B1 (it) 3,4 - diidro- 6- benzil-4-oxopirimidine sostituite e relativo processodi produzione e impiego nella terapia delle infezioni da hiv-1.
AU2000255628A1 (en) Formulation comprising thymol useful in the treatment of drug resistant bacterial infections
CL2004000261A1 (es) Procedimiento para la eliminacion de virus en soluciones de fibrinogeno de aplicacion terapeutica.
BRPI0208998A2 (pt) formulação farmacêutica com gosto dissumulado e seu processo de preparo
EP1404281A4 (en) TOPICAL USE PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF SKIN AND / OR MUCOSAL LESIONS, USE OF COMPOSITIONS AND COMPOUNDS IN THE TREATMENT OF SKIN AND / OR MUCOUS DISEASES
AU2002325169A1 (en) Pharmaceutical composition for the prophylaxis and/or treatment of virus diseases
AU2003244132A1 (en) Method of examining allergic disaese and drug for treating the same
EP1389204A4 (en) NEW SULPHONAMIDE DERIVATIVES, THEIR INTERMEDIATES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITION CONTAINING THESE COMPOUNDS

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: PARA.INT.CI.A61K 47/44, A61K 9/08, A61K 31/704, A61P 31/00

Ipc: A61K 47/44 (2011.01), A61K 9/08 (2011.01), A61K 31

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 12/11/2013, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 11/04/2002 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B21A Patent or certificate of addition expired [chapter 21.1 patent gazette]

Free format text: PATENTE EXTINTA EM 11.04.2022